Form D — Solstice Oncology, Inc.
0002116600-26-000002 · filed 2026-03-09
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $298,400,851
- Total sold
- $121,260,306
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Solstice Oncology, Inc.
- CIK
- 2116600
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 200 BERKELEY ST., 18TH FLOOR
BOSTON, MA 02116 - Phone
- 617-982-2331
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
CAROLINE LOEW · Executive OfficerBoston, MA Find on LinkedIn ↗
-
EMILY MINKOW · DirectorBoston, MA Find on LinkedIn ↗
-
ANDREW LEVIN · DirectorBoston, MA Find on LinkedIn ↗
-
MORGAN HALLER · DirectorBoston, MA Find on LinkedIn ↗
-
JULIE GRANT · DirectorBoston, MA Find on LinkedIn ↗
-
Maiken Keson-Brookes · Executive OfficerBoston, MA Find on LinkedIn ↗
-
David Feltquate · Executive OfficerBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.